White C, Gardiner E, Eisman J
Bone & Mineral Research Program, Garvan Institute of Medical Research, St Vincent's Hospital, Darlinghurst, Sydney, Australia.
Mol Biol Rep. 1998 Jan;25(1):45-61. doi: 10.1023/a:1006820710966.
Studies of gene expression in bone have adopted a number of molecular approaches that seek to determine those cis and trans-acting factors responsible for the development and physiological regulation of this unique tissue. The majority of studies have been performed in vitro, focussing on the expression of genes such as osteocalcin, bone sialoprotein and type I collagen which demonstrate restricted or altered expression patterns in osteoblasts. These studies have demonstrated a large number of cis and trans acting factors that modulate the tissue specific and vitamin D responsive expression of these genes. These include the response elements and regions mediating basal and vitamin D dependent transcription of these genes as well as some of the transcription factors that bind to these regions and the nucleosomal organisation of these genes within a nuclear framework. In vivo studies, including the introduction of transgenes into transgenic mice, extend these in vitro observations within a physiological context. However, in part due to limitations in each approach, these in vitro and in vivo studies are yet to accurately define all the necessary cis and trans-acting factors required for tissue specific and vitamin D responsive gene expression. Advances have been made in identifying many cis-acting regions within the flanking regions of these genes that are responsible for their restricted expression patterns, but a vector incorporating all the necessary cis-acting regions capable of directing gene expression independent of integration site has not yet been described. Similarly, trans-acting factors that determine the developmental destiny of osteoblast progenitors and the restricted expression of these genes remain elusive and, despite advances in the understanding of protein-DNA interactions at vitamin D response elements contained within these genes, further intermediary factors that interact with the transcriptional machinery to modulate vitamin D responsiveness need to be identified.
对骨中基因表达的研究采用了多种分子方法,旨在确定那些负责这种独特组织发育和生理调节的顺式和反式作用因子。大多数研究是在体外进行的,重点关注骨钙素、骨唾液蛋白和I型胶原蛋白等基因的表达,这些基因在成骨细胞中表现出受限或改变的表达模式。这些研究已经证明了大量调节这些基因组织特异性和维生素D反应性表达的顺式和反式作用因子。这些因子包括介导这些基因基础转录和维生素D依赖性转录的反应元件和区域,以及一些与这些区域结合的转录因子,以及这些基因在核框架内的核小体组织。体内研究,包括将转基因引入转基因小鼠,在生理背景下扩展了这些体外观察结果。然而,部分由于每种方法的局限性,这些体外和体内研究尚未准确界定组织特异性和维生素D反应性基因表达所需的所有必要顺式和反式作用因子。在确定这些基因侧翼区域内许多负责其受限表达模式的顺式作用区域方面已经取得了进展,但尚未描述一种包含所有能够独立于整合位点指导基因表达的必要顺式作用区域的载体。同样,决定成骨细胞祖细胞发育命运和这些基因受限表达的反式作用因子仍然难以捉摸,尽管在理解这些基因中所含维生素D反应元件处的蛋白质-DNA相互作用方面取得了进展,但仍需要鉴定与转录机制相互作用以调节维生素D反应性的其他中间因子。